1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

prevalence

Page 1 of 3
  1. SNT Gatchaman
    Thread

    Preprint Unequal access to diagnosis of myalgic encephalomyelitis in England, 2024, Ponting and Samms

    Unequal access to diagnosis of myalgic encephalomyelitis in England Chris P Ponting; Gemma L Samms People with Myalgic Encephalomyelitis (ME/CFS;...
    Thread by: SNT Gatchaman, Feb 2, 2024, 15 replies, in forum: ME/CFS research
  2. LarsSG
    Thread

    Prevalence of covid-19 and long covid in collegiate student athletes from spring 2020 to fall 2021: a retrospective survey, 2023, Massey

    Abstract Background Symptomatic COVID-19 and Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 (PASC) or post-COVID conditions,...
    Thread by: LarsSG, Dec 14, 2023, 3 replies, in forum: Long Covid research
  3. Wyva
    Thread

    CDC Data Brief: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults: United States, 2021–2022, 2023, Vahratian, Unger et al

    Key findings Data from the National Health Interview Survey In 2021–2022, 1.3% of adults had myalgic encephalomyelitis/chronic fatigue syndrome...
    Thread by: Wyva, Dec 8, 2023, 40 replies, in forum: ME/CFS research
  4. ahimsa
    Thread

    Medscape: 3 Years Into Long COVID: Where Do We Go From Here? (by Lisa McCorkell, Patient-Led Research Collaborative)

    3 Years Into Long COVID: Where Do We Go From Here? https://www.medscape.com/viewarticle/993827 "... approximately 6% of all US adults are...
    Thread by: ahimsa, Jul 1, 2023, 6 replies, in forum: Long Covid news
  5. SNT Gatchaman
    Thread

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC), 2023, Bonilla et al

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19...
    Thread by: SNT Gatchaman, Mar 13, 2023, 0 replies, in forum: Long Covid research
  6. John Mac
    Thread

    A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID 2022 Kakeya et al

    A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID Abstract Long-term sequelae of the coronavirus disease...
    Thread by: John Mac, Dec 27, 2022, 0 replies, in forum: Long Covid research
  7. John Mac
    Thread

    Prevalence and Correlates of Long COVID Symptoms Among US Adults Perlis et al 2022

    Key Points Question How common are COVID-19 symptoms lasting longer than 2 months, also known as long COVID, among adults in the United States,...
    Thread by: John Mac, Oct 27, 2022, 0 replies, in forum: Long Covid research
  8. cassava7
    Thread

    ME/CFS in the world, elsewhere than in Europe, USA and Oceania

    The vast majority of research on ME/CFS, including epidemiological data, comes from Europe, the USA, Oceania, and to a lesser extent Japan and...
    Thread by: cassava7, Oct 10, 2022, 5 replies, in forum: Epidemiology (incidence, prevalence, prognosis)
  9. cassava7
    Thread

    The Prevalence of Chronic Fatigue Syndrome in Nigeria, Njoku, Torres-Harding and Jason, 2007

    The present study found adult rates of chronic fatigue syndrome (CFS) in Nigeria that were somewhat higher than rates from community-based CFS...
    Thread by: cassava7, Oct 10, 2022, 2 replies, in forum: ME/CFS research
  10. LarsSG
    Thread

    Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection, 2022, Antar et al

    Abstract Little data exist on long COVID outcomes beyond one year. In a cohort enrolled with mild-moderate acute COVID-19, a wide range of...
    Thread by: LarsSG, Aug 10, 2022, 1 replies, in forum: Long Covid research
  11. Wyva
    Thread

    Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?, 2022, Orji et

    Abstract Background ME/CFS is a disorder characterized by recurrent fatigue and intolerance to exertion which manifests as profound...
    Thread by: Wyva, Aug 10, 2022, 13 replies, in forum: ME/CFS research
  12. Wyva
    Thread

    Co-morbidities - prevalence in people with ME/CFS

    Post copied from this thread: EDS, hypermobility, and the link, if any, to ME/CFS I didn't know where to post this, but the ME Association had an...
    Thread by: Wyva, Jul 25, 2022, 15 replies, in forum: General and other signs and symptoms
  13. Wyva
    Thread

    Updated ME/CFS prevalence estimates reflecting post-COVID increases and associated economic costs and funding implications, 2022, Mirin, Jason et al

    ABSTRACT In this article, we update our earlier analyses of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) economic impact and its...
    Thread by: Wyva, Apr 12, 2022, 5 replies, in forum: ME/CFS research
  14. Kalliope
    Thread

    Preprint: Prevalence, determinants, and impact on general health and working capacity of PASC 6-12 m after infection..., 2022, Peter, Kern et al

    Prevalence, determinants, and impact on general health and working capacity of post-acute sequelae of COVID-19 six to 12 month after infection: a...
    Thread by: Kalliope, Mar 15, 2022, 11 replies, in forum: Long Covid research
  15. ME/CFS Skeptic
    Thread

    Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea, Lim et al. 2021

    Abstract Background: Chronic fatigue syndrome (CFS) is a long-term disabling illness accompanied by medically unexplained fatigue. This study...
    Thread by: ME/CFS Skeptic, Dec 11, 2021, 4 replies, in forum: Psychosomatic news - ME/CFS and Long Covid
  16. ola_cohn
    Thread

    Associations between long-term conditions and upper gastrointestinal cancer incidence: UK Biobank, 2021, Marley et al

    Associations between long-term conditions and upper gastrointestinal cancer incidence: A prospective population-based cohort of UK Biobank...
    Thread by: ola_cohn, Nov 27, 2021, 0 replies, in forum: ME/CFS research
  17. Andy
    Thread

    Prevalence of Chronic Fatigue Syndrome (CFS) in Korea and Japan: A Meta-Analysis, 2021, Lim and Son

    Abstract Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term disabling illness accompanied by fatigue unsolved...
    Thread by: Andy, Aug 8, 2021, 11 replies, in forum: Psychosomatic research - ME/CFS and Long Covid
  18. Andy
    Thread

    Office of National Statistics: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: Updates

    "Main points At 2 May 2021, an estimated 1.0 million people living in private households in the UK (1.6%) were experiencing self-reported long...
    Thread by: Andy, Jun 4, 2021, 133 replies, in forum: Long Covid news
  19. Sly Saint
    Thread

    Prevalence of (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care, 2011, Lacerda,Nacul

    Not new but thought it should be here. " Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) or chronic fatigue...
    Thread by: Sly Saint, Apr 11, 2021, 15 replies, in forum: ME/CFS research
  20. ME/CFS Skeptic
    Thread

    Long Covid epidemiology (prevalence, incidence, recovery rates)

    moved thread The long covid groups seem to believe that long covid is often associated with mild initial disease and not having antibodies on...
    Thread by: ME/CFS Skeptic, Feb 20, 2021, 69 replies, in forum: Long Covid news
Showing results 1 to 20 of 44
Page 1 of 3